Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing Syndrome

Corcept Therapeutics

Status: Terminated

Conditions: Cushing Syndrome; Hypercortisolism

Study type: Observational

Funder types: Industry

Identifiers

NCT03379363

C1073-900

Details and patient eligibility

About

This retrospective, multi-center, chart review study will collect patient data from medical charts of pediatric patients who have been treated with Korlym for Cushing's syndrome.

Full description

This retrospective chart review study seeks to collect data from pediatric patients treated with Korlym (mifepristone) to help provide clinicians with some insight on the potential role of mifepristone in the treatment of pediatric patients with Cushing syndrome.

Only sites that have been identified to have patients appropriate for this protocol will be invited to participate and contribute data on their patients

Data to be collected from a retrospective chart review will include:

• Patient demographics
• Medical history
• Pre and post treatment clinical assessments and laboratory results
• Radiologic findings (if available)
• Adverse events

Data will be collected for all follow-up visits, up until the most recent encounter prior to IRB approval.

Enrollment: 2 patients

Sex: All

Ages: Under 21 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Pediatrics (age≤21 years) at time Korlym initiation
• Considered to have a diagnosis of endogenous Cushing's syndrome by the healthcare provider
• Received at least one dose of Korlym
• Availability of pre-treatment (baseline) and follow-up data

Exclusion criteria

• None

Trial design

2 participants in 1 patient group

Pediatric Cushing Syndrome Patients

Description:

Pediatrics patients with endogenous Cushing syndrome who received at least one dose of Korlym